Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446.

Qiu X, Wang Z, Li Y, Miao Y, Ren Y, Luan Y.

Cancer Lett. 2012 Oct 28;323(2):161-70. doi: 10.1016/j.canlet.2012.04.004. Epub 2012 Apr 17.

PMID:
22521544
2.

Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.

Meng X, Li M, Wang X, Wang Y, Ma D.

Cancer Sci. 2009 Jun;100(6):1040-6. doi: 10.1111/j.1349-7006.2009.01144.x. Epub 2009 Feb 20.

3.

Biologic characteristics of the side population of human small cell lung cancer cell line H446.

Wang B, Yang H, Huang YZ, Yan RH, Liu FJ, Zhang JN.

Chin J Cancer. 2010 Mar;29(3):254-60.

4.

Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.

Sun FF, Hu YH, Xiong LP, Tu XY, Zhao JH, Chen SS, Song J, Ye XQ.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6287-300. eCollection 2015.

5.

Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.

Morrison BJ, Steel JC, Morris JC.

PLoS One. 2012;7(11):e49752. doi: 10.1371/journal.pone.0049752. Epub 2012 Nov 13.

6.

Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.

Srivastava VK, Nalbantoglu J.

Cytometry A. 2008 Oct;73(10):940-8. doi: 10.1002/cyto.a.20633.

7.

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.

Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, Ku HH, Chiou SH.

PLoS One. 2008 Jul 9;3(7):e2637. doi: 10.1371/journal.pone.0002637.

8.

Identification and expansion of the tumorigenic lung cancer stem cell population.

Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R.

Cell Death Differ. 2008 Mar;15(3):504-14. Epub 2007 Nov 30.

9.

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.

Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W.

Int J Cancer. 2012 Jan 1;130(1):29-39. doi: 10.1002/ijc.25967. Epub 2011 Apr 8.

10.

Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma.

Ma B, Lei X, Guan Y, Mou LS, Yuan YF, Yue H, Lu Y, Xu GT, Qian J.

Oncol Rep. 2011 Jul;26(1):135-43. doi: 10.3892/or.2011.1291. Epub 2011 Apr 29.

PMID:
21573498
11.

miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.

Miao Y, Li J, Qiu X, Li Y, Wang Z, Luan Y.

Oncol Rep. 2013 Jan;29(1):161-8. doi: 10.3892/or.2012.2095. Epub 2012 Oct 19.

PMID:
23117485
12.

CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.

Cui F, Wang J, Chen D, Chen YJ.

Oncol Rep. 2011 Mar;25(3):701-8. doi: 10.3892/or.2010.1115. Epub 2010 Dec 20.

PMID:
21174061
13.

[Isolation and identification of CD133 positive and negative cells from human lung cancer and screening of the differential genes between the positive and negative cells].

Zheng S, Li S, Wang H, Xie X, Zhang Y.

Zhongguo Fei Ai Za Zhi. 2015 Mar;18(3):123-30. doi: 10.3779/j.issn.1009-3419.2015.03.01. Chinese.

14.

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.

Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, CalabrĂ² E, Pastorino U, Sozzi G.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16281-6. doi: 10.1073/pnas.0905653106. Epub 2009 Sep 10.

15.

Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y, Wong MP.

PLoS One. 2010 Nov 19;5(11):e14062. doi: 10.1371/journal.pone.0014062.

16.

CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.

Shi CJ, Gao J, Wang M, Wang X, Tian R, Zhu F, Shen M, Qin RY.

World J Gastroenterol. 2011 Jun 28;17(24):2965-71. doi: 10.3748/wjg.v17.i24.2965.

17.

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.

Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.

J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. doi: 10.1093/jnci/djq361. Epub 2010 Oct 8.

18.
19.

CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.

Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, Li X, He Z, Gong W, Qin R.

Cancer Biol Ther. 2010 Dec 1;10(11):1182-90. Epub 2010 Dec 1.

PMID:
20948317
20.

ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.

Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.

PLoS One. 2011;6(6):e20636. doi: 10.1371/journal.pone.0020636. Epub 2011 Jun 13.

Supplemental Content

Support Center